Vertex Pharmaceuticals VRTX Shares Repurchased

Other financials

Revenue$3.0B+7.8%

Gross profit$2.6B+7.8%

Operating income$1.1B+80.6%

Net income$1.0B+59.6%

EPS (diluted)$4.02+61.4%

Cash & equivalents$5.5B+17.5%

Total debt$2.0B+20.5%

Total equity$19.4B+17.4%

Total assets$26.5B+15.8%

Operating cash flow$1.4B+74.4%

CapEx$133.4M+228%

Free cash flow$1.3B+66.4%

Market cap$114.63B-8.9%

Enterprise value$111.11B-9.5%

P/E26.4×—

P/S9.4×-2.0×

Gross margin86.2%+0.2pp

Operating margin38.3%—

Net margin35.5%—

FCF margin30.4%+20.2pp

Return on equity24.2%—

Debt / equity0.1×0.0×

Current ratio3×+0.4×